GridAI Technologies GRDX
NASDAQ GRDX
$2.97 -0.05 (-1.66%)
At close: Sep 10, 2026 · 4:00 PM EDT

GridAI Technologies (GRDX) Assets Average (2016 - 2026)

GridAI Technologies' (GRDX) quarterly Assets Average came in at $42.8 million in Q2 2026, down 49.73% on a YoY basis from $85.1 million in Q2 2025, and down 53.47% quarter-over-quarter from $92.0 million in Q4 2025.

Analysis

GridAI Technologies (GRDX) Assets Average (2016 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Assets Average for 11 consecutive years, with $42.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Assets Average fell 49.73% year-over-year to $42.8 million; the trailing twelve-month figure through Jun 2026 stood at $42.8 million (down 49.73% YoY), and the FY2025 full-year result was $67.0 million, up 45.15% from the prior year.
  • Assets Average slipped to $42.8 million in Q2 2026 per GRDX's latest filing, from $92.0 million in the prior quarter.
  • Across five years, Assets Average topped out at $110.2 million in Q3 2025 and bottomed at $4.3 million in Q3 2022.
  • Historically, Assets Average has averaged $45.5 million across 5 years, with a median of $42.8 million in 2026.
  • The sharpest annual moves came in 2022 and 2024: Assets Average sank 67.28% in 2022, then jumped 1699.07% in 2024.
  • Over 5 years, Assets Average stood at $5.0 million in 2022, then gained by 27.02% to $6.4 million in 2023, then soared by 1236.64% to $85.6 million in 2024, then gained by 7.41% to $92.0 million in 2025, then slumped by 53.47% to $42.8 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $42.8 million, $92.0 million, and $110.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 5.34 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 30.78 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.51 Bn
10 GridAI Technologies 19.07 Mn 19.07 Mn -36,514.00 42.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.79 Mn
Dec 31, 2025 91.96 Mn
Sep 30, 2025 110.21 Mn
Jun 30, 2025 85.13 Mn
Mar 31, 2025 85.31 Mn
Dec 31, 2024 85.62 Mn
Sep 30, 2024 86.05 Mn
Jun 30, 2024 88.71 Mn
Mar 31, 2024 49.01 Mn
Dec 31, 2023 6.41 Mn
Sep 30, 2023 5.13 Mn
Jun 30, 2023 4.93 Mn
Mar 31, 2023 5.49 Mn
Dec 31, 2022 5.04 Mn
Sep 30, 2022 4.29 Mn
Jun 30, 2022 6.38 Mn
Mar 31, 2022 10.31 Mn
Dec 31, 2021 12.11 Mn
Sep 30, 2021 13.10 Mn
Jun 30, 2021 15.88 Mn